• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Intellia Therapeutics

layoffs job cuts workforce reduction layoff
Biotech

Intellia cuts 27% of staff as it takes ax to pipeline

Intellia is axing 27% of its staffers as it tosses out pipeline assets to keep the engine running until a potential commercial launch in 2027.
Ben Adams Jan 10, 2025 4:00am
heart cardiovascular check up stethescope

Intellia, Alnylam post data on contrasting cardiomyopathy ideas

Nov 18, 2024 7:40am
CRISPR Therapeutics

Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks

Oct 24, 2024 8:55am
eggs big and small

Intellia doesn't need to re-dose NTLA-2001. But it can be done

Jun 25, 2024 3:31pm
start race starting block runners go advance

Intellia showcases durability of one-and-done HAE option

Jun 2, 2024 8:00am
Graphic of a fork in the road with arrows pointing in either direction

Intellia opts out of hemophilia gene editing work with Regeneron

Mar 22, 2024 11:21am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings